Utilization and procedural adverse outcomes associated with Watchman device implantation

Khalil, F; Arora, S; Killu, AM; Tripathi, B; DeSimone, CV; Egbe, A; Noseworthy, PA; Kapa, S; Mulpuru, S; Gersh, B; Mohamad, A; Friedman, P; Holmes, D; Deshmukh, AJ

Deshmukh, AJ (corresponding author), Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55901 USA.

EUROPACE, 2021; 23 (2): 247

Abstract

Aims The Food and Drug Administration (FDA) approval of the Watchman device [percutaneous left atrial appendage occlusion (LAAO)] has resulted in the ......

Full Text Link